sp comp5
5

Quentin Descat

Head Global Cardiovascular – Commercial Launch Brands Lead

CASE STUDY

The Employer Experience Proposition

Global Internal Benchmark for key HR Metrics. Key HR Metrics are aggregated and shared globally between different regions so each region can compare their own results with others within Sony. This is a good use case of how own data is utilised and leveraged in a global scale.

sp comp3
3

Quentin Descat

Head Global Cardiovascular – Commercial Launch Brands Lead

CASE STUDY

The Employer Experience Proposition

Global Internal Benchmark for key HR Metrics. Key HR Metrics are aggregated and shared globally between different regions so each region can compare their own results with others within Sony. This is a good use case of how own data is utilised and leveraged in a global scale.

Speakers

Sample of Keynote Speakers and their Case Studies

sp comp1
2

Quentin Descat

Head Global Cardiovascular – Commercial Launch Brands Lead

CASE STUDY

The Employer Experience Proposition

Global Internal Benchmark for key HR Metrics. Key HR Metrics are aggregated and shared globally between different regions so each region can compare their own results with others within Sony. This is a good use case of how own data is utilised and leveraged in a global scale.

Слайдшоу
Logo Bayer.svg
Eva Bretschneider Bayer

Eva Bretschneider

Patient Engagement Strategy Lead

CASE STUDY

From Participation to Partnership: Redefining Patient Engagement in Clinical Trials

Medical advancements rely on the active engagement of individuals with lived experiences to shape and participate in clinical trials. This session will delve into how the pharmaceutical industry can cultivate stronger partnerships with patient communities, enhancing representation and enriching the overall participant experience. Attendees will discover how leveraging patient narratives can inform clinical programmes and foster long-term collaborations that drive meaningful change.

AstraZeneca logo.svg
Gabor Mate Bartok AstraZeneca

Gábor Máté Bartók

Associate Director Patient Safety

CASE STUDY

Enhancing Patient Support Programme at the Affiliate Level: Best Practices and Key Considerations

The role of patient engagement and insights are critical in the pharmaceutical industry. Understanding patient needs, concerns, and experiences is essential for driving advancements in healthcare. But is the local PV system ready to handle the incoming information? Key points to consider from planning to programme final report from PV perspective.

Pre-Start Phase:

1.Patient Safety Review:

  • Assess patient demographics, drug specifics, AE (Adverse Event) incidence rates, available resources, and programme design fundamentals
  • Integrate multifaceted support resources, including call centres, educational materials, and digital tools

2.Contracting Essentials:

  • Determine the need for standalone PVAs (Pharmacovigilance Agreements) or safety clauses
  • Critical contract elements: Include audit rights, clear definitions, mandatory training, AE reporting procedures, contact details, and reconciliation processes

3.AE Training and Vendor Setup:

  • Implement comprehensive AE training protocols
  • Establish a robust vendor monitoring strategy with clear KPIs, defined monitoring frequency, and audit readiness

During the Programme:

1.Vendor Performance and AE Monitoring:

  • Conduct regular vendor reviews to ensure compliance with contractual obligations
  • Maintain ongoing reconciliation and monitor AE trends to identify any emerging issues

Post Completion:

1.Study Reporting:

  • Prepare a comprehensive study report summarising outcomes, key learnings, and areas for improvement
Show More
Novartis
Katrina Lucking Novartis

Katrina Lucking

Head, Therapeutic Area (TA) Communications and Patient Advocacy

CASE STUDY

Amplifying Patient Advocacy to Transform Healthcare Together

Customer Experience is the ultimate expression of competitive advantage. It is the job of every one of your employees, it must be built comprehensively and intentionally, run on data, and cannot be delegated to a team of experts — it is the single most important outcome of your innovation efforts. Join this talk for a practical take on implementing a customer experience management system that powers innovation across the entire product lifecycle.

In an evolving landscape where customer expectations continually rise, understanding and proactively addressing customer needs is no longer optional—it’s essential. This session explores how empathy-driven customer experience (CX), combined with strategic automation and cutting-edge AI, can radically enhance efficiency, agent performance, and customer loyalty. Leveraging real-world insights and innovative frameworks, discover practical ways to future-proof your contact centre operations.

Show More
gilead sciences 1
Phil Noll Gilead Sciences

Phil Noll

Associate Director Medical HIV Patient Affairs

CASE STUDY

Revolutionising the Pharma Operating Model for Patient Driven Transformation

The pharmaceutical industry stands at a pivotal moment. To truly deliver on our promise of improving lives, we must reimagine our operating model to place patients at the heart of every decision. I believe that a patient-driven transformation is not just an aspiration but a necessity to drive innovation, enhance trust, and deliver meaningful outcomes globally. This presentation outlines a bold vision to revolutionise how we operate, ensuring that patient insights shape our strategies, processes, and impact.

In today’s rapidly evolving digital landscape, the banking sector faces increasingly sophisticated cyber threats. As banks continue to innovate and expand their digital services, ensuring robust cybersecurity measures is more critical than ever. This presentation, titled “Evolving Cybersecurity in the Banking Sector: Strategies for Adapting to Emerging Threats,” will explore the latest trends in cyber threats, discuss effective strategies for mitigating risks, and highlight best practices for maintaining security in an ever-changing environment. Join us as we delve into the challenges and solutions that are shaping the future of cybersecurity in banking.

Show More
KyowaKirin BrandLogo color 3
Gabor Purman Kyowa Kirin International

Gabor Purman

Patient Advocacy Director

CASE STUDY

Lived Experiences? Why They matter?

How to visualise lived experiences of rare blood cancer?
Why do patients suffer more than they should?
Why and how to collaborate with PAGs on actionable insights?
What channels can be used to explain lived experiences with rare blood cancer?

In today’s rapidly evolving digital landscape, businesses must innovate to stay ahead. AI is no longer just an advantage — it’s a necessity for optimising operations, enhancing decision-making, and driving growth. This presentation explores how AI transforms business operations through:

Show More
Thumbnail 1
Thumbnail 2
Thumbnail 3
Thumbnail 4
Thumbnail 5
6666bayer6666bayer
Logo Bayer.svg
Eva Bretschneider Bayer

Eva Bretschneider

Patient Engagement Strategy Lead

CASE STUDY

From Participation to Partnership: Redefining Patient Engagement in Clinical Trials

Medical advancements rely on the active engagement of individuals with lived experiences to shape and participate in clinical trials. This session will delve into how the pharmaceutical industry can cultivate stronger partnerships with patient communities, enhancing representation and enriching the overall participant experience. Attendees will discover how leveraging patient narratives can inform clinical programmes and foster long-term collaborations that drive meaningful change.

22
AstraZeneca logo.svg
Gabor Mate Bartok AstraZeneca

Gábor Máté Bartók

Associate Director Patient Safety

CASE STUDY

Enhancing Patient Support Programme at the Affiliate Level: Best Practices and Key Considerations

The role of patient engagement and insights are critical in the pharmaceutical industry. Understanding patient needs, concerns, and experiences is essential for driving advancements in healthcare. But is the local PV system ready to handle the incoming information? Key points to consider from planning to programme final report from PV perspective.

Pre-Start Phase:

1.Patient Safety Review:

  • Assess patient demographics, drug specifics, AE (Adverse Event) incidence rates, available resources, and programme design fundamentals
  • Integrate multifaceted support resources, including call centres, educational materials, and digital tools

2.Contracting Essentials:

  • Determine the need for standalone PVAs (Pharmacovigilance Agreements) or safety clauses
  • Critical contract elements: Include audit rights, clear definitions, mandatory training, AE reporting procedures, contact details, and reconciliation processes

3.AE Training and Vendor Setup:

  • Implement comprehensive AE training protocols
  • Establish a robust vendor monitoring strategy with clear KPIs, defined monitoring frequency, and audit readiness

During the Programme:

1.Vendor Performance and AE Monitoring:

  • Conduct regular vendor reviews to ensure compliance with contractual obligations
  • Maintain ongoing reconciliation and monitor AE trends to identify any emerging issues

Post Completion:

1.Study Reporting:

  • Prepare a comprehensive study report summarising outcomes, key learnings, and areas for improvement
Show More
33
KyowaKirin BrandLogo color 3
Gabor Purman Kyowa Kirin International

Gabor Purman

Patient Advocacy Director

CASE STUDY

Lived Experiences? Why They matter?

How to visualise lived experiences of rare blood cancer?
Why do patients suffer more than they should?
Why and how to collaborate with PAGs on actionable insights?
What channels can be used to explain lived experiences with rare blood cancer?

In today’s rapidly evolving digital landscape, businesses must innovate to stay ahead. AI is no longer just an advantage — it’s a necessity for optimising operations, enhancing decision-making, and driving growth. This presentation explores how AI transforms business operations through:

Show More
44
Novartis
Katrina Lucking Novartis

Katrina Lucking

Head, Therapeutic Area (TA) Communications and Patient Advocacy

CASE STUDY

Amplifying Patient Advocacy to Transform Healthcare Together

Customer Experience is the ultimate expression of competitive advantage. It is the job of every one of your employees, it must be built comprehensively and intentionally, run on data, and cannot be delegated to a team of experts — it is the single most important outcome of your innovation efforts. Join this talk for a practical take on implementing a customer experience management system that powers innovation across the entire product lifecycle.

In an evolving landscape where customer expectations continually rise, understanding and proactively addressing customer needs is no longer optional—it’s essential. This session explores how empathy-driven customer experience (CX), combined with strategic automation and cutting-edge AI, can radically enhance efficiency, agent performance, and customer loyalty. Leveraging real-world insights and innovative frameworks, discover practical ways to future-proof your contact centre operations.

Show More
77777gilead77777gilead
gilead sciences 1
Phil Noll Gilead Sciences

Phil Noll

Associate Director Medical HIV Patient Affairs

CASE STUDY

Revolutionising the Pharma Operating Model for Patient Driven Transformation

The pharmaceutical industry stands at a pivotal moment. To truly deliver on our promise of improving lives, we must reimagine our operating model to place patients at the heart of every decision. I believe that a patient-driven transformation is not just an aspiration but a necessity to drive innovation, enhance trust, and deliver meaningful outcomes globally. This presentation outlines a bold vision to revolutionise how we operate, ensuring that patient insights shape our strategies, processes, and impact.

In today’s rapidly evolving digital landscape, the banking sector faces increasingly sophisticated cyber threats. As banks continue to innovate and expand their digital services, ensuring robust cybersecurity measures is more critical than ever. This presentation, titled “Evolving Cybersecurity in the Banking Sector: Strategies for Adapting to Emerging Threats,” will explore the latest trends in cyber threats, discuss effective strategies for mitigating risks, and highlight best practices for maintaining security in an ever-changing environment. Join us as we delve into the challenges and solutions that are shaping the future of cybersecurity in banking.

Show More